Novartis India acquires Pfizer trademarks for Rs 1,250 crore
Acquiring Company
Novartis India Ltd
Acquired Company
Pfizer
Switzerland
New YorkBiotechnologyHealth CarepharmaceuticalsBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsDescription
Novartis India has acquired trademarks and related intellectual property rights from Pfizer for Rs 1,250 crore. The deal was approved by Novartis India's board on September 7 and includes the brands 'Minipress' and 'Minipres'. The signing and closing of the transaction will occur simultaneously. This acquisition aims to enhance Novartis India's portfolio in the pharmaceutical sector.
Don't miss Novartis India Ltd's next move
Get an email the moment Novartis India Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Pfizer?
Pfizer was acquired by Novartis India Ltd, based in Switzerland. The deal was reported on September 7, 2026. Novartis India Ltd is a subsidiary of Novartis AG, focusing on healthcare products for chronic conditions. The company has a diverse portfolio including diabetes, neurology, and cardiology therapies. Novartis India Ltd is publicly traded (NVS) and operates in Biotechnology.
When did Novartis India Ltd acquire Pfizer?
Novartis India Ltd's acquisition of Pfizer was reported on September 7, 2026. Novartis India has acquired trademarks and related intellectual property rights from Pfizer for Rs 1,250 crore. The deal was approved by Novartis India's board on September 7 and includes the brands 'Minipress' and 'Minipres'. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pfizer do?
Seagen is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in antibody-drug conjugates and has a portfolio of targeted therapies. It is publicly traded (PFE), operating in Biotechnology, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.